Analysts' Actions: Allergan Gains, Houghton Mifflin Tumbles

NEW YORK ( TheStreet) --  Houghton Mifflin  ( HMHC) was tumbling 5.6% to $16.77 after Morgan Stanley initiated coverage with an overweight rating and a 12-month price target of $20. The publisher is a  market leader and should benefit from a recovery in spending, Morgan Stanley said.

Archer-Daniels Midland ( ADM) was adding 0.7% to $43.34 after coverage of the shares was initiated with a hold rating at Stifel Nicolaus. It's a valuation call, as the stock has gained 58% year to date, Stifel Nicolaus said.

Allergan ( AGN) was gaining 1.1% to $108.58 on an upgrade from Wells Fargo to outperform from market perform. 

Caesars Entertainment ( CZR) was slipping 0.3% to $20.20 as TheStreet Ratings initiated coverage with a sell rating. 

[Read: 4 Stocks Spiking on Big Volume]

Stock Comments / EPS Changes

Schlumberger (SLB) estimates were cut at Credit Suisse. Estimates were reduced through 2015, Credit Suisse said. Iraq incident, weaker seismic results and poor weather will weigh on earnings, Credit Suisse said. Neutral rating and $105 price target.

Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

If you liked this article you might like

You Better Buy Apple Here, a Top Chart-Loving Analyst Says

Bunge Says There Are No Talks with Suitor Glencore

Mnuchin Puts Kibosh on Border Tax as House Debates Measure